NCT05641324 2024-02-12A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)Anaveon AGPhase 1 Terminated4 enrolled
NCT02189343 2019-11-21Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple MyelomaCelgenePhase 1 Completed16 enrolled